• About BreezyScroll
  • Privacy & Policy
  • Contact Us
Sunday, May 11, 2025
BreezyScroll
ADVERTISEMENT
  • Home
  • Breezy Stories
  • Technology
  • Gaming
  • Entertainment
  • Lifestyle
  • World
  • Money
  • Sports
  • Breezy Explainer
No Result
View All Result
  • Home
  • Breezy Stories
  • Technology
  • Gaming
  • Entertainment
  • Lifestyle
  • World
  • Money
  • Sports
  • Breezy Explainer
No Result
View All Result
BreezyScroll
No Result
View All Result

Home  /  Health  /  Breakthrough in Alzheimer’s research: Eli Lilly’s Alzheimer’s drug shows promise in slowing cognitive decline

Breakthrough in Alzheimer’s research: Eli Lilly’s Alzheimer’s drug shows promise in slowing cognitive decline

by Siddhi Vinayak Misra
July 19, 2023
in Health
Reading Time: 2 mins read
Breakthrough in Alzheimer's research: Eli Lilly's Alzheimer's drug shows promise in slowing cognitive decline

Donanemab, a breakthrough medicine, has emerged as a crucial milestone in the fight against persistent forgetfulness or Alzheimer’s disease, following a global trial that validated its potential to reduce cognitive loss. Eli Lilly, a US pharmaceutical company, presented the full results of its phase 3 clinical research of Donanemab on Monday at the Alzheimer’s Association International Conference in Amsterdam. The data showed that the antibody treatment delayed disease progression by roughly 35% in the early stages.

ADVERTISEMENT

A harmful protein accumulates in the brain of a person suffering from dementia. The aforementioned drug is said to help in the early stages of the condition by removing this specific protein. The Donanemab trial included 1,736 people aged 73 on average. The trial participants had mild to moderate Alzheimer’s disease symptoms, and half received intravenous infusions of the medication and the other half a placebo every four weeks for 18 months. According to reports, Eli Lilly’s medicine halted the progression of the disease, most effectively in its early stages.

So, is it a dementia cure?

Not quite. While the medicine is not a cure, several humanitarian organizations believe the findings published in the journal JAMA herald a new era in Alzheimer’s treatment. The medication is only effective in treating Alzheimer’s disease and not in treating other types of dementia, such as vascular dementia.

What happens next for Donanemab?

The medicine is currently being evaluated for prospective use in the National Health Service (NHS) by the United Kingdom’s drug regulatory agency. Donanemab demonstrated a roughly one-third reduction in disease progression during the studies.

ADVERTISEMENT

Donanemab is manufactured by Indianapolis-headquartered Eli Lilly

Donanemab is manufactured by Indianapolis-headquartered Eli Lilly, which also operates lecanemab, a medicine created by Eisai and Biogen that has earned international recognition for its demonstrated ability to halt the disease. While these treatments have a lot of potential, it’s crucial to remember that they’re not without hazards.

Donanemab breakthrough: Potential risks

Brain swelling surfaced as a common side effect in the Donanemab trial, affecting up to one-third of patients. However, for the vast majority of people, this problem resolved itself without generating any symptoms.

ShareTweetShareSend
ADVERTISEMENT
ADVERTISEMENT

Recent Articles

India’s iron shield: DRDO’s D4 anti-drone system proves formidable at border—All about it

India’s iron shield: DRDO’s D4 anti-drone system proves formidable at border—All about it

May 10, 2025
“Enough is Enough”: After EaseMyTrip And Cox & Kings, Ixigo halts bookings to Turkey, China, and Azerbaijan

“Enough is Enough”: After EaseMyTrip And Cox & Kings, Ixigo halts bookings to Turkey, China, and Azerbaijan

May 10, 2025
Osama bin Laden, nukes, and djinns: The shadowy past behind Pakistan Army’s media chief

Osama bin Laden, nukes, and djinns: The shadowy past behind Pakistan Army’s media chief

May 10, 2025
Breezy Explainer: What is an air defense system and how India shot down Pakistan’s drone and Fatah missile attacks

Breezy Explainer: What is an air defense system and how India shot down Pakistan’s drone and Fatah missile attacks

May 10, 2025
BreezyScroll Logo

BreezyScroll is a global content platform that provides a unique experience of enhancing the knowledge quotient for its audience by providing the latest news and updates from various categories such as politics, sports, entertainment, technology, and more.
The platform aims to provide a concise and easy-to-read format for its users. BreezyScroll covers news stories from around the world, majorly the United States. The platform was launched in 2021 and has become one of the fastest-growing content companies in the US.

Follow Us

Browse by Category

  • Africa
  • Animals
  • Asia
  • Athletics
  • Australia
  • Auto
  • Basketball
  • Bollywood
  • Brand
  • Breezy Explainer
  • Breezy Feature
  • Breezy Soul
  • Business
  • Canada
  • Chess
  • China
  • Coronavirus
  • Cricket
  • Education
  • Entertainment
  • Environment
  • EPL
  • Europe
  • Exclusive Interview
  • Exclusive Review
  • Football
  • Gaming
  • Health
  • Hollywood
  • India
  • International
  • K Pop
  • Law
  • Lifestyle
  • Middle East
  • Money
  • NFL
  • North America
  • OTT
  • Paris Olympics
  • Pets
  • Press Releases
  • Russia
  • Science
  • South America
  • Space
  • Sports
  • Startup
  • Technology
  • Tennis
  • Tennis
  • The Achievers
  • The US
  • Travel
  • UK
  • UK
  • Uncategorized
  • World
  • WWE

Trending Topics

Afghanistan AI Apple Australia Biden California Canada China Climate Change Coronavirus COVID-19 Donald Trump Elon Musk Featured Florida Google IPL Japan Joe Biden Mars Meta Moon NASA NBA Netflix New York North Korea Ohio Omicron Putin Queen Elizabeth II Russia Russia-Ukraine crisis South Korea SpaceX Taliban Tesla Texas TikTok Trump Twitter UK Ukraine USA Virat Kohli

No Result
View All Result
  • About BreezyScroll
  • Privacy & Policy
  • Contact Us

© 2024 · BreezyScroll.com

No Result
View All Result
  • Home
  • Breezy Stories
  • Technology
  • Gaming
  • Entertainment
  • Lifestyle
  • World
  • Money
  • Sports
  • Breezy Explainer

© 2024 · BreezyScroll.com

Go to mobile version